ConductScience.org, home

Paper2826656

Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus.

Daniel MD and 6 others. J Gen Virol, 1987. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. Papers, record 2826656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2826656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus.
PubMed
Journal
J Gen Virol
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
4.15
iCite
Revised in PubMed
2007-11-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daniel MDM D
2Letvin NLN L
3Sehgal PKP K
4Hunsmann GG
5Schmidt DKD K
6King NWN W
7Desrosiers RCR C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Disease Models, AnimalMajor topic
MacacaMajor topic
Macaca mulattaMajor topic
Retroviridae InfectionsMajor topic
Animals
Antibodies, Viral
Neutralization Tests
Retroviridae
Time Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI20729NIAID NIH HHSUnited StatesR01AI020729PubMed and NIHNIH RePORTER
CA34949NCI NIH HHSUnited StatesPubMedPubMed
CA38205NCI NIH HHSUnited StatesR01CA038205PubMed and NIHNIH RePORTER
R37AI020729NIHNIH RePORTER

Download CSV of grants

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
34667304Fertility preservation in boys facing gonadotoxic cancer therapy.Nat Rev Urol2022https://conductscience.org/library/papers/34667304PubMed
24043694The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.Mol Hum Reprod2014https://conductscience.org/library/papers/24043694PubMed
21937655Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.J Virol2011https://conductscience.org/library/papers/21937655PubMed
18541726Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18541726PubMed
18454679Adaptive evolution of simian immunodeficiency viruses isolated from 2 conventional-progressor macaques with encephalitis.J Infect Dis2008https://conductscience.org/library/papers/18454679PubMed
18272584Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery.J Virol2008https://conductscience.org/library/papers/18272584PubMed
17719201Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.Brain Behav Immun2008https://conductscience.org/library/papers/17719201PubMed
17574643Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Virology2007https://conductscience.org/library/papers/17574643PubMed
15039205Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGb.Am J Pathol2004https://conductscience.org/library/papers/15039205PubMed
14512533
Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
J Virol2003https://conductscience.org/library/papers/14512533PubMed
12941910Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.J Virol2003https://conductscience.org/library/papers/12941910PubMed
11679158Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.AIDS Res Hum Retroviruses2001https://conductscience.org/library/papers/11679158PubMed
11148000Infectious disease issues in xenotransplantation.Clin Microbiol Rev2001https://conductscience.org/library/papers/11148000PubMed
10933680Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.J Virol2000https://conductscience.org/library/papers/10933680PubMed
10888632Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.J Virol2000https://conductscience.org/library/papers/10888632PubMed
10364376Persistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: replication kinetics and genomic stability.J Virol1999https://conductscience.org/library/papers/10364376PubMed
10233957Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.J Virol1999https://conductscience.org/library/papers/10233957PubMed
9811741
Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
J Virol1998https://conductscience.org/library/papers/9811741PubMed
9517942
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9517942PubMed
9445063CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.J Virol1998https://conductscience.org/library/papers/9445063PubMed

See all 61 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2826656

GET https://conductscience.org/api/papers/v1/2826656/cited_by?page=2